LYMPHOMA, PRIMARY CUTANEOUS ANAPLASTIC LARGE CELL

Clinical trials for LYMPHOMA, PRIMARY CUTANEOUS ANAPLASTIC LARGE CELL explained in plain language.

Never miss a new study

Get alerted when new LYMPHOMA, PRIMARY CUTANEOUS ANAPLASTIC LARGE CELL trials appear

Sign up with your email to follow new studies for LYMPHOMA, PRIMARY CUTANEOUS ANAPLASTIC LARGE CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Targeted therapy tested for Hard-to-Treat skin cancers

Disease control Ongoing

This study tested whether the drug brentuximab vedotin could help control three types of CD30-positive skin lymphomas in patients whose disease had come back or did not respond to prior treatments. The drug is designed to find and enter cancer cells with a specific marker (CD30) …

Matched conditions: LYMPHOMA, PRIMARY CUTANEOUS ANAPLASTIC LARGE CELL

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

LYMPHOMA, PRIMARY CUTANEOUS ANAPLASTIC LARGE CELL

Get alerted when new LYMPHOMA, PRIMARY CUTANEOUS ANAPLASTIC LARGE CELL trials appear

Targeted therapy tested for Hard-to-Treat skin cancers